MEDRx USA, Inc.

Quick facts

Phase 3 pipeline

• Etodolac-lidocaine topical patch · Pain Management
  Etodolac-lidocaine topical patch delivers a nonsteroidal anti-inflammatory drug (NSAID) and local anesthetic directly to affected tissue to reduce pain and inflammation.
• MRX-7EAT · Diabetes
  MRX-7EAT is a small molecule that targets the SGLT2 receptor.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• MEDRx USA, Inc. portfolio CI brief
• MEDRx USA, Inc. pipeline updates RSS